- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 116.65M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 114.58M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $149.04M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $64.39M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $67.46M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $185.61M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.37B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $765.95M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $4.92B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.8B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $443.68M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $440.31M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.52B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $923.47M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $8.21B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $8.4B |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $8.04B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.09 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.12 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $102.71M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $116.42M |
| Net Income | Q1 2026 · Mar 31, 2026 | $144.59M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $7.47M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $143.82M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$33.93M |
| Revenue | Q1 2026 · Mar 31, 2026 | $257.73M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $263.19M |